EARNEST PARTNERS LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$83,101,259
-2.0%
815,838
-2.9%
0.48%
+1.1%
Q2 2023$84,765,207
+8.3%
840,008
-1.3%
0.47%
+4.6%
Q1 2023$78,270,104
+0.7%
850,762
-0.7%
0.45%
-5.0%
Q4 2022$77,754,025
+17.3%
857,077
-1.7%
0.48%
+7.2%
Q3 2022$66,259,000
-9.6%
871,718
+0.6%
0.44%
-8.8%
Q2 2022$73,282,000
-6.5%
866,934
-3.0%
0.49%
+5.2%
Q1 2022$78,407,000
-0.9%
893,526
-1.2%
0.46%
+1.5%
Q4 2021$79,144,000
+2.7%
904,818
-4.0%
0.46%
-3.0%
Q3 2021$77,054,000
-15.1%
942,212
-5.3%
0.47%
-11.8%
Q2 2021$90,807,000
-0.9%
995,249
-7.2%
0.53%
-2.6%
Q1 2021$91,667,000
-2.2%
1,072,381
+8.0%
0.55%
-15.4%
Q4 2020$93,743,000
+10.9%
992,723
+2.1%
0.65%
-11.1%
Q3 2020$84,531,000
-2.3%
972,062
-1.9%
0.73%
-10.8%
Q2 2020$86,517,000
-21.3%
990,580
-25.7%
0.82%
-34.0%
Q1 2020$109,891,000
-39.0%
1,332,821
-29.9%
1.24%
-12.5%
Q4 2019$180,098,000
+6.8%
1,901,979
-2.0%
1.42%
-7.1%
Q3 2019$168,609,000
-4.3%
1,940,267
+0.6%
1.52%
-4.3%
Q2 2019$176,136,000
-6.0%
1,928,986
-1.1%
1.59%
-11.1%
Q1 2019$187,428,000
+13.5%
1,949,530
+1.3%
1.79%
-0.4%
Q4 2018$165,120,000
-1.8%
1,924,256
-1.4%
1.80%
+19.4%
Q3 2018$168,094,000
+12.7%
1,950,955
-1.2%
1.51%
+8.0%
Q2 2018$149,097,000
-6.4%
1,973,750
+0.2%
1.40%
-7.4%
Q1 2018$159,311,000
-5.0%
1,970,449
-1.4%
1.51%
-6.2%
Q4 2017$167,734,000
-2.6%
1,997,788
-0.4%
1.61%
-6.4%
Q3 2017$172,238,000
+0.7%
2,006,267
-2.1%
1.72%
-4.5%
Q2 2017$171,118,000
+11.2%
2,050,058
-1.1%
1.80%
+9.4%
Q1 2017$153,913,000
+1.5%
2,072,349
-0.5%
1.64%
-0.8%
Q4 2016$151,689,000
+7.1%
2,082,494
+16.1%
1.66%
+11.5%
Q3 2016$141,610,000
-8.1%
1,793,439
-4.0%
1.48%
-11.2%
Q2 2016$154,153,000
+0.6%
1,868,298
-11.6%
1.67%
+4.2%
Q1 2016$153,160,000
-17.9%
2,114,303
-2.4%
1.60%
-15.6%
Q4 2015$186,449,000
-9.2%
2,167,007
-3.0%
1.90%
-5.8%
Q3 2015$205,282,000
-6.1%
2,233,264
+0.4%
2.02%
+5.6%
Q2 2015$218,680,000
+2.4%
2,223,712
+2.7%
1.91%
+3.9%
Q1 2015$213,540,000
+2.2%
2,165,497
-4.0%
1.84%
+7.2%
Q4 2014$208,908,000
+0.5%
2,254,568
+2.1%
1.72%
-1.3%
Q3 2014$207,788,000
-1.8%
2,207,462
-5.5%
1.74%
+3.1%
Q2 2014$211,534,000
+4.9%
2,336,621
-1.4%
1.68%
+4.1%
Q1 2014$201,579,000
+8.9%
2,370,955
+3.0%
1.62%
+9.0%
Q4 2013$185,064,0002,302,3581.48%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders